メールサービス キャンペーン : 期間中に新規登録や配信希望カテゴリの変更等をされた方に、ご用意した無料レポートを提供しております。 新規登録 / 登録内容変更

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の中心静脈カテーテル市場:医療機器のパイプライン評価

Central Venous Catheters - Medical Devices Pipeline Assessment, 2018

発行 GlobalData 商品コード 229188
出版日 ページ情報 英文 82 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.61円で換算しております。
Back to Top
世界の中心静脈カテーテル市場:医療機器のパイプライン評価 Central Venous Catheters - Medical Devices Pipeline Assessment, 2018
出版日: 2018年06月14日 ページ情報: 英文 82 Pages
概要

当レポートでは、世界の中心静脈カテーテル市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (資本取引・事業提携など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 中心静脈カテーテル市場の概要

第3章 治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • パイプライン製品:現在進行中の治験

第4章 中心静脈カテーテル:治験中のパイプライン製品 (企業別)

  • 中心静脈カテーテルの企業:治験段階別のパイプライン製品
  • 中心静脈カテーテル:治験段階別のパイプライン製品

第5章 中心静脈カテーテル:企業・製品の概要

  • Ash Access Technology, Inc.
    • パイプライン製品および進行中の治験の概要
  • Bluegrass Vascular Technologies, Inc.
  • Charite - Universitatsmedizin Berlin
  • Globe Medical Tech, Inc.
  • i360medical Limited
  • Infusense Corp
  • Marvao Medical Devices Limited
  • ニプロ
  • Pavmed Inc
  • S3V Vascular Technologies
  • Sharklet Technologies, Inc.
  • Teleflex Incorporated
  • The Johns Hopkins University
  • The University of Utah
  • Vascular Access Technologies, Inc.
  • Vindica Therapeutics, Inc

第6章 中心静脈カテーテル市場:昨今の動向

第7章 付録

図表一覧

目次
Product Code: GDME0602EPD

GlobalData's Medical Devices sector report, "Central Venous Catheters - Medical Devices Pipeline Assessment, 2018" provides an overview of Central Venous Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Central Venous Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Central Venous Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Central Venous Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Central Venous Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 Central Venous Catheters Overview 6

3 Products under Development 7

  • 3.1 Central Venous Catheters - Pipeline Products by Stage of Development 7
  • 3.2 Central Venous Catheters - Pipeline Products by Segment 8
  • 3.3 Central Venous Catheters - Pipeline Products by Territory 9
  • 3.4 Central Venous Catheters - Pipeline Products by Regulatory Path 10
  • 3.5 Central Venous Catheters - Pipeline Products by Estimated Approval Date 11

4 Central Venous Catheters - Pipeline Products under Development by Companies 12

  • 4.1 Central Venous Catheters Companies - Pipeline Products by Stage of Development 12
  • 4.2 Central Venous Catheters - Pipeline Products by Stage of Development 13

5 Central Venous Catheters Companies and Product Overview 14

  • 5.1 Ash Access Technology Inc Company Overview 14
  • 5.2 Bactiguard Holding AB Company Overview 15
  • 5.3 Charite University Hospital of Berlin Company Overview 16
  • 5.4 Globe Medical Tech Inc (Inactive) Company Overview 17
  • 5.5 Infusense Corp Company Overview 18
  • 5.6 Marvao Medical Devices Ltd Company Overview 19
  • 5.7 Nipro Corp Company Overview 20
  • 5.8 Pavmed Inc Company Overview 21
  • 5.9 Protectus Medical Devices, Inc. Company Overview 22
  • 5.10 S3V Vascular Technologies Company Overview 23
  • 5.11 Sharklet Technologies Inc Company Overview 24
  • 5.12 Silmag SA Company Overview 25
  • 5.13 Silver Bullet Therapeutics, Inc. Company Overview 27
  • 5.14 Teleflex Inc Company Overview 28
  • 5.15 University of Illinois at Chicago Company Overview 29
  • 5.16 University of Utah Company Overview 30
  • 5.17 Vindica Therapeutics, Inc Company Overview 31

6 Central Venous Catheters- Recent Developments 32

  • 6.1 Jun 01, 2018: BD Appoints John DeFord As Chief Technology Officer 32
  • 6.2 May 22, 2018: PAVmed Announces First Quarter 2018 Financial Results 32
  • 6.3 May 15, 2018: B. Braun Brings Its Commitment to The Safe Handling of Hazardous Drugs to ONS 2018 34
  • 6.4 May 15, 2018: Retractable Technologies Announces Results as of March 31, 2018; Operating Loss Declined by 86.4% 35
  • 6.5 May 11, 2018: BioCardia Reports First Quarter 2018 Financial Results And Business Highlights 36
  • 6.6 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives 36
  • 6.7 May 09, 2018: ICU Medical Announces First Quarter 2018 Results 37
  • 6.8 May 03, 2018: BD Announces Results For 2018 Second Fiscal Quarter; Raises Fiscal 2018 Guidance 38
  • 6.9 May 03, 2018: Teleflex Reports First Quarter 2018 Results 40
  • 6.10 Apr 27, 2018: BD Names Three Executives to Segment Leadership Roles 42
  • 6.11 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management 43
  • 6.12 Apr 18, 2018: B. Braun Opens Five New Medical Production Facilities in Penang 44
  • 6.13 Apr 02, 2018: Retractable Technologies Reports Results for the Year 2017 44
  • 6.14 Mar 23, 2018: 2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros 45
  • 6.15 Mar 21, 2018: BioCardia Announces Fourth Quarter 2017 Financial Results 47
  • 6.16 Mar 07, 2018: Bactiguard launches line extension to BIP CVC 48
  • 6.17 Mar 01, 2018: ICU Medical Announces Fourth Quarter and Fiscal Year 2017 Results 48
  • 6.18 Mar 01, 2018: Poly Medicure: Commencement of Commercial Production 49
  • 6.19 Feb 22, 2018: Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance 49
  • 6.20 Feb 13, 2018: Four start-ups chosen for the B. Braun Accelerator Program 52
  • 6.21 Feb 12, 2018: Region Skane extends agreement with Bactiguard 52
  • 6.22 Feb 06, 2018: BD Announces Results For 2018 First Fiscal Quarter; Provides Fiscal 2018 Guidance Updated For Inclusion Of Bard 53
  • 6.23 Jan 18, 2018: B. Braun to Showcase Comprehensive Parenteral Nutrition Program, New Compounder and More at ASPEN 54
  • 6.24 Jan 02, 2018: Teleflex Completes Previously Announced CEO Transition 55
  • 6.25 Dec 15, 2017: B. Braun Launches Introcan Safety Deep Access IV Catheters 56
  • 6.26 Dec 12, 2017: B. Braun establishes a subsidiary in Zambia 56
  • 6.27 Nov 15, 2017: PAVmed Reports Third Quarter 2017 Financial Results 57
  • 6.28 Nov 14, 2017: Retractable Technologies Announces Results as of September 30, 2017 59
  • 6.29 Nov 14, 2017: Inserting And Removing Central Venous Catheters Cause Significant Discomfort In Cancer Patients And At Times Is Unnecessary 60
  • 6.30 Nov 13, 2017: i360medical partners with Baptist Hospital South Florida to Launch Innovation Institute Miami 60
  • 6.31 Nov 10, 2017: New clinical study shows fewer adverse events with Bactiguard's central venous catheter compared to a standard central venous catheter 61
  • 6.32 Nov 10, 2017: BioCardia Reports Third Quarter 2017 Financial Results and Business Highlights 62
  • 6.33 Nov 09, 2017: ICU Medical Announces Third Quarter 2017 Results 62
  • 6.34 Nov 07, 2017: Dr. Ian McNiece Appointed BioCardia Chief Scientific Officer 63
  • 6.35 Nov 02, 2017: Teleflex Reports Third Quarter 2017 Results 64
  • 6.36 Oct 12, 2017: CAPS to Showcase Latest 503B Quality Assurance Capabilities and Expansion Plans at Health Connect Reverse Expo - Fall Hospital Pharmacy Conference 66
  • 6.37 Oct 04, 2017: Bactiguard's Central Venous Catheters Approved in Hong Kong 66
  • 6.38 Aug 30, 2017: Bactiguard's Central Venous Catheters Approved in India 67
  • 6.39 Aug 23, 2017: Teleflex Awarded Group Purchasing Contract with Vizient for Non-Tunneled Central Venous Catheters 67
  • 6.40 Aug 18, 2017: District Court Issues Final Judgment - Retractable Technologies v. Becton, Dickinson 68
  • 6.41 Aug 14, 2017: PAVmed Reports Second Quarter 2017 Financial Results 68
  • 6.42 Aug 14, 2017: Retractable Technologies Reports Results as of June 30, 2017 70
  • 6.43 Aug 09, 2017: ICU Medical Announces Second Quarter 2017 Results 71
  • 6.44 Aug 03, 2017: BD Announces Results For 2017 Third Fiscal Quarter 72
  • 6.45 Aug 03, 2017: Teleflex Reports Second Quarter 2017 Results 73
  • 6.46 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 75
  • 6.47 Jul 28, 2017: Indonesian Minister of Health Launches New German Pharmaceutical Factory in Karawang 75
  • 6.48 Jun 29, 2017: Angel Catheter Pivotal Study Published in Journal of Vascular and Interventional Radiology 76
  • 6.49 Jun 14, 2017: i360medical Announces Ray Cantwell as Chairman of the Board 77

7 Appendix 78

  • 7.1 Methodology 78
  • 7.2 About GlobalData 81
  • 7.3 Contact Us 81
  • 7.4 Disclaimer 81

List of Tables

1.1 List of Tables

  • Table 1: Central Venous Catheters - Pipeline Products by Stage of Development 8
  • Table 2: Central Venous Catheters - Pipeline Products by Segment 9
  • Table 3: Central Venous Catheters - Pipeline Products by Territory 10
  • Table 4: Central Venous Catheters - Pipeline Products by Regulatory Path 11
  • Table 5: Central Venous Catheters - Pipeline Products by Estimated Approval Date 12
  • Table 6: Central Venous Catheters Companies - Pipeline Products by Stage of Development 13
  • Table 7: Central Venous Catheters - Pipeline Products by Stage of Development 14
  • Table 8: Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 15
  • Table 9: BaxCath Impregnation System - Product Status 15
  • Table 10: BaxCath Impregnation System - Product Description 15
  • Table 11: Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 12: Transvascular Injection Catheter - Product Status 16
  • Table 13: Transvascular Injection Catheter - Product Description 16
  • Table 14: Charite University Hospital of Berlin Pipeline Products & Ongoing Clinical Trials Overview 17
  • Table 15: Central Venous Permanent Catheter - Product Status 17
  • Table 16: Central Venous Permanent Catheter - Product Description 17
  • Table 17: Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 18
  • Table 18: Safety IV Catheter - Product Status 18
  • Table 19: Safety IV Catheter - Product Description 18
  • Table 20: Infusense Corp Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 21: Infusense System - Product Status 19
  • Table 22: Infusense System - Product Description 19
  • Table 23: Marvao Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 24: NexSite 8Fr Single Lumen Central Venous Catheter - Product Status 20
  • Table 25: NexSite 8Fr Single Lumen Central Venous Catheter - Product Description 20
  • Table 26: Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 21
  • Table 27: Biocompatible Intravenous Catheter - Product Status 21
  • Table 28: Biocompatible Intravenous Catheter - Product Description 21
  • Table 29: Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 30: NextCath - Product Status 22
  • Table 31: NextCath - Product Description 22
  • Table 32: Protectus Medical Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 33: Safety IV Catheter - Product Status 23
  • Table 34: Safety IV Catheter - Product Description 23
  • Table 35: S3V Vascular Technologies Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 36: 3V AGILE - Product Status 24
  • Table 37: 3V AGILE - Product Description 24
  • Table 38: Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 39: Sharklet Central Venous Catheter - Product Status 25
  • Table 40: Sharklet Central Venous Catheter - Product Description 25
  • Table 41: Silmag SA Pipeline Products & Ongoing Clinical Trials Overview 26
  • Table 42: Umbilical Artery Catheter - Product Status 26
  • Table 43: Umbilical Artery Catheter - Product Description 26
  • Table 44: Umbilical Vein Catheter - Product Status 27
  • Table 45: Umbilical Vein Catheter - Product Description 27
  • Table 46: Silver Bullet Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 47: Cathanic Venous Catheter - Product Status 28
  • Table 48: Cathanic Venous Catheter - Product Description 28
  • Table 49: Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 50: ARROW JACC Nurse Insertion CVC System - Product Status 29
  • Table 51: ARROW JACC Nurse Insertion CVC System - Product Description 29
  • Table 52: University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 53: Extendable Intravenous Catheter - Product Status 30
  • Table 54: Extendable Intravenous Catheter - Product Description 30
  • Table 55: University of Utah Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 56: WIN NIC Central Venous Catheter Introducer Kit - Product Status 31
  • Table 57: WIN NIC Central Venous Catheter Introducer Kit - Product Description 31
  • Table 58: Vindica Therapeutics, Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 59: Anti-Thrombotic And Anti-Infective Central Venous Catheter - Product Status 32
  • Table 60: Anti-Thrombotic And Anti-Infective Central Venous Catheter - Product Description 32
  • Table 61: Glossary 81

List of Figures

1.2 List of Figures

  • Figure 1: Central Venous Catheters - Pipeline Products by Stage of Development 8
  • Figure 2: Central Venous Catheters - Pipeline Products by Segment 9
  • Figure 3: Central Venous Catheters - Pipeline Products by Territory 10
  • Figure 4: Central Venous Catheters - Pipeline Products by Regulatory Path 11
  • Figure 5: Central Venous Catheters - Pipeline Products by Estimated Approval Date 12
Back to Top